{"id":19881,"date":"2026-01-14T18:13:02","date_gmt":"2026-01-14T18:13:02","guid":{"rendered":"https:\/\/bitunikey.com\/news\/enlivex-bets-big-on-crypto-prediction-markets-while-advancing-osteoarthritis-therapy\/"},"modified":"2026-01-14T18:13:16","modified_gmt":"2026-01-14T18:13:16","slug":"enlivex-bets-big-on-crypto-prediction-markets-while-advancing-osteoarthritis-therapy","status":"publish","type":"post","link":"https:\/\/bitunikey.com\/news\/enlivex-bets-big-on-crypto-prediction-markets-while-advancing-osteoarthritis-therapy\/","title":{"rendered":"Enlivex bets big on crypto prediction markets while advancing osteoarthritis therapy"},"content":{"rendered":"<p><\/p>\n<div class=\"post-detail__content blocks\">\n<p class=\"is-style-lead\">Enlivex Therapeutics Ltd. is blending biotech with blockchain. <\/p>\n<div id=\"cn-block-summary-block_acefcfe804edfa7852132f03e508851d\" class=\"cn-block-summary\">\n<div class=\"cn-block-summary__nav tabs\">\n        <span class=\"tabs__item is-selected\">Summary<\/span>\n    <\/div>\n<div class=\"cn-block-summary__content\">\n<ul class=\"wp-block-list\">\n<li>Enlivex Therapeutics raised $212 million through a private equity deal and is using much of it to build a digital asset treasury via the RAIN token, a decentralized prediction market protocol. <\/li>\n<li>The company holds roughly 76 billion RAIN tokens and an option to buy nearly $918 million more at a deep discount, which analysts say could create a major unpriced value driver. <\/li>\n<li>Meanwhile, its osteoarthritis therapy Allocetra continues to show promising results in clinical trials. HC Wainwright reaffirmed a Buy rating on Enlivex and raised its 12-month price target to $13, citing both the RAIN token strategy and clinical progress.<\/li>\n<\/ul><\/div>\n<\/div>\n<p><!-- .cn-block-summary --><\/p>\n<p class=\"is-style-default\">The clinical-stage company, known for its osteoarthritis drug Allocetra, last year raised $212 million in a private equity deal and is now deploying a large portion of the proceeds to build a digital asset treasury anchored in prediction markets.<\/p>\n<p>The move centers on the RAIN token, a fully decentralized prediction and options protocol on the Arbitrum network. Enlivex purchased 212 million RAIN tokens at $1 per share, funded in a mix of U.S. dollars and USDT, using them to implement what the company calls its first RAIN token treasury strategy. <\/p>\n<p>The RAIN platform allows anyone to create and trade custom markets, with outcomes resolved via AI and governed by a deflationary buy-and-burn token mechanism. <\/p>\n<h3 class=\"wp-block-heading\">RAIN undervalued<\/h3>\n<p>HC Wainwright &amp; Co.\u2019s Raghuram Selvaraju flagged the token as undervalued, noting that Enlivex\u2019s holdings of roughly 76 billion RAIN tokens\u2014plus an option to buy nearly $918 million more at $0.0033 per token\u2014could create a future value driver currently unpriced by the market.<\/p>\n<p>Since its launch in September 2025, RAIN has seen $1.5 billion in trading volume over 3.5 months, with daily volumes averaging $55 million. Analysts cite precedent projects such as Polymarket and Kalshi, which reached an $11 billion valuation, as evidence of the growth potential in decentralized prediction markets.<\/p>\n<p>Enlivex isn\u2019t leaving its biotech ambitions behind. Allocetra continues to show promising results in osteoarthritis trials, with six-month data demonstrating substantial pain reduction and functional improvement in patients aged 60 and older. Additional studies in basal thumb osteoarthritis are expected to report top-line results in the coming months.<\/p>\n<p>HC Wainwright reiterated a Buy rating on Enlivex, raising its 12-month price target to $13 per share, citing both the potential of the RAIN token treasury and ongoing clinical progress with Allocetra.<\/p>\n<p>    <!-- .cn-block-related-link --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Enlivex Therapeutics Ltd. is blending biotech with blockchain. Summary Enlivex Therapeutics raised $212 million through a private equity deal and is using much of it to build a digital asset&hellip;<\/p>\n","protected":false},"author":1,"featured_media":11551,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-19881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cryptocurrency"],"_links":{"self":[{"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/posts\/19881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/comments?post=19881"}],"version-history":[{"count":1,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/posts\/19881\/revisions"}],"predecessor-version":[{"id":19882,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/posts\/19881\/revisions\/19882"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/media\/11551"}],"wp:attachment":[{"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/media?parent=19881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/categories?post=19881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bitunikey.com\/news\/wp-json\/wp\/v2\/tags?post=19881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}